Foresite Capital Opportunity Management V, LLC - Insider Non-Derivative Transactions at Kinnate Biopharma Inc. (KNTE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 8, 2023, Foresite Capital Opportunity Management V, LLC's relationship to Kinnate Biopharma Inc. (KNTE) is TenPercentOwner, and currently has 3,525,957 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KNTE insiders.

Data Source: SEC.
Foresite Capital Opportunity Management V, LLC - Insider Non-Derivative Transactions of KNTE Common Stock
Foresite Capital Opportunity Management V, LLC - Insider Non-Derivative Transactions at KNTE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
May 9, 2023 P -- (Common Stock) 229044 2.8 520711
May 9, 2023 P -- (Common Stock) 1550956 2.8 3525957
Feb 18, 2023 J -- (Common Stock) 1100000 0 1975001